A three-stage, modified-blind, dose-escalating study to assess efficacy and safety of resiquimod gel for the treatment of common warts in adults.

Trial Profile

A three-stage, modified-blind, dose-escalating study to assess efficacy and safety of resiquimod gel for the treatment of common warts in adults.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2007

At a glance

  • Drugs Resiquimod (Primary)
  • Indications Warts
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Feb 2007 Additional lead trial center (Medicis Global Service Corporation) identified as reported by ClinicalTrials.gov.
    • 16 Feb 2007 Companies added in association field as reported by ClinicalTrials.gov.
    • 10 Nov 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top